CEL-SCI notifies availability of Multikine Phase 3 confirmatory study launch releasePUBT·Jul 13 at 07:01 AMCVM-0.84%
CEL-SCI signs agreement with Saudi Amarox to support Multikine commercialization in Saudi ArabiaPUBT·Jun 24 at 07:01 AMCVM-0.84%
CEL-SCI Completes $2.5M Stock Offering at $1.00, Engages ThinkEquity as Placement AgentTradingView·Jun 16 at 04:13 PMCVM-0.84%
CEL-SCI Corporation Announces Pricing of Offering | CVM Stock NewsStockTitan·Jun 14 at 10:03 AMCVM-0.84%
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia | CVM Stock NewsStockTitan·Jun 11 at 11:00 PMCVM-0.84%
U.S. stock market update: CEL-SCI's stock price fell by 10.47%, and insider trading confidence failed to boost market sentimentPrice Alert·May 19 at 02:18 PMCVM-0.84%
Pre-market hot trades in US stocks: Cel-Sci up 7.38% in pre-market, can management's buyback and progress in cancer immunotherapy offset financial weakness?Price Alert·May 18 at 07:32 AMCVM-0.84%
Cel-Sci Forms Multikine Commercialization Partnership in Middle EastTip Ranks·May 14 at 06:34 PMCVM-0.84%
CEL-SCI Raises $7.2 Million in Stock Offering; Placement Agreement With ThinkEquityTradingView·May 13 at 03:53 PMCVM-0.84%
